Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 87

Results For "SMA"

949 News Found

Digital health-start-up MFine raises US $ 48 million
Startup | September 29, 2021

Digital health-start-up MFine raises US $ 48 million

Since its inception, over three million users have used MFine services with the platform clocking over three lakh monthly transactions


B2B pharma start-up MEDdelivery raises US $ 1 million
Startup | September 28, 2021

B2B pharma start-up MEDdelivery raises US $ 1 million

The company operates in over eight cities and the start-up plans to expand its reach to over 100 non-metro cities in the next 18-24 months


Health Sensei wins Stanford Seed Spark competition
Startup | September 24, 2021

Health Sensei wins Stanford Seed Spark competition

Seed Spark is an online entrepreneurship program offered by Stanford Seed. Health Sensei emerged as a winner competing with 86 startups from their May-Aug 2021 graduating cohort


Lonza to expand its drug manufacturing network in Switzerland
Biotech | September 23, 2021

Lonza to expand its drug manufacturing network in Switzerland

Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, has announced it will invest in additional drug product manufacturing capabilities in Switzerland


MergerDomo facilitates fundraising for health food and wellness startups
Startup | September 22, 2021

MergerDomo facilitates fundraising for health food and wellness startups

The two startups will utilise the capital for business growth including strategic expansion, product development, R&D and technology investments


Pfizer and BioNTech’s Covid-19 vaccine safe for children aged 5 to 11: study
Biotech | September 21, 2021

Pfizer and BioNTech’s Covid-19 vaccine safe for children aged 5 to 11: study

In participants 5 to 11 years of age, the vaccine was safe, well-tolerated and showed robust neutralising antibody responses. Results in children under 5 years of age are expected as soon as later this year


AstraZeneca to set up API facility in Ireland at an investment of US $ 360 million
Supply Chain | September 21, 2021

AstraZeneca to set up API facility in Ireland at an investment of US $ 360 million

The investment programme is expected to significantly reduce commercialisation lead times, costs and introduce more sustainable manufacturing processes


Carmat announces first implant of its artificial heart in a woman
Healthcare | September 21, 2021

Carmat announces first implant of its artificial heart in a woman

The recipient is a 57-year-old woman who was suffering from severe biventricular heart failure and had undergone cardiac surgery several years ago


Imfinzi plus chemotherapy tripled patient survival at 3 years
Biotech | September 20, 2021

Imfinzi plus chemotherapy tripled patient survival at 3 years

The CASPIAN Phase III trial in extensive-stage small-cell lung cancer is the longest survival follow-up ever reported for immunotherapy treatment in this setting


CDSCO approves Exablate 4000 for patients living with Parkinson’s disease
Medical Device | September 20, 2021

CDSCO approves Exablate 4000 for patients living with Parkinson’s disease

The approval will enable the treatment of patients in India living with Essential tremor, tremor-dominant Parkinson's Disease and neuropathic pain